Cargando…
Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152630/ https://www.ncbi.nlm.nih.gov/pubmed/25197175 http://dx.doi.org/10.4103/0971-5851.138960 |
| _version_ | 1782333153644380160 |
|---|---|
| author | Junior, Gilberto de Lima Lopes |
| author_facet | Junior, Gilberto de Lima Lopes |
| author_sort | Junior, Gilberto de Lima Lopes |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4152630 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41526302014-09-05 Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014 Junior, Gilberto de Lima Lopes Indian J Med Paediatr Oncol Comments and Controversies Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4152630/ /pubmed/25197175 http://dx.doi.org/10.4103/0971-5851.138960 Text en Copyright: © Indian Journal of Medical and Paediatric Oncology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Comments and Controversies Junior, Gilberto de Lima Lopes Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014 |
| title | Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014 |
| title_full | Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014 |
| title_fullStr | Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014 |
| title_full_unstemmed | Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014 |
| title_short | Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014 |
| title_sort | controversies in colorectal cancer: first line treatment with epidermal growth factor inhibitors and ras in 2014 |
| topic | Comments and Controversies |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152630/ https://www.ncbi.nlm.nih.gov/pubmed/25197175 http://dx.doi.org/10.4103/0971-5851.138960 |
| work_keys_str_mv | AT juniorgilbertodelimalopes controversiesincolorectalcancerfirstlinetreatmentwithepidermalgrowthfactorinhibitorsandrasin2014 |